Lilly To Pay Miss. $18.5M Over Zyprexa Marketing
By Christie Smythe ( February 4, 2010, 5:26 PM EST) -- Eli Lilly and Co. Inc. has agreed to pay Mississippi $18.5 million to settle the state's allegations that the drugmaker marketed its antipsychotic Zyprexa for off-label uses and failed to reveal risks that the drug could cause diabetes....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.